Immunological Analysis of a CCHFV mRNA Vaccine Candidate in Mouse Models.

Clicks: 373
ID: 61177
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #4 of 18 articles by views in Vaccines

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Development of new vaccine platforms against viral diseases is considered urgent. In recent years, mRNA constructs have attracted great interest in this field due to unique advantages over conventional gene transfer platforms. In the present study, we developed a new naked conventional mRNA vaccine expressing the non-optimized small (S) segment of the Ank-2 strain of Crimean-Congo Hemorrhagic Fever virus (CCHFV). We then analyzed its single and booster dose immunogenicity and protection potential in the challenge assay in two mice models, including IFNα/β/γR and C57BL/6. The results obtained from the immunological assays, namely IL-4 and IFN-gamma ELISPOT, intracellular IFN-gamma staining, in-house sandwich ELISA, and survival data, demonstrated that our construct elicited the production of anti-nucleocapsid (N) specific immune responses in both mice models. A 100% protection rate was only obtained in the booster dose group of IFNα/β/γR mice, indicating that this platform needs further optimization in future studies. In conclusion, we assessed a novel approach in CCHFV vaccination by introducing a conventional mRNA platform which can be considered in future experiments as an efficient and safe way to battle this disease.
Reference Key
aligholipour-farzani2019immunologicalvaccines Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Aligholipour Farzani, Touraj;Földes, Katalin;Ergünay, Koray;Gurdal, Hakan;Bastug, Aliye;Ozkul, Aykut;
Journal Vaccines
Year 2019
DOI
E115
URL
Keywords
cchfv ifnα/β/γr−/− conventional naked mrna specific immune responses stroke ear acupuncture acupuncture near infrared spectroscopy body acupuncture laser stimulation scalp acupuncture microbiota rabbit phagocytic activity morphometry enterocin sage biopolymer miscibility composite extrusion

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.